Transcripts

Roivant Sciences (ROIV) earnings call transcripts

Earnings call transcripts for Roivant Sciences Ltd., with a summary, the guidance given, and what analysts pressed on.

  • Q1 2026 earnings call

    Management framed the quarter as a calm-before-the-storm period, with commercial launch and multiple clinical readouts making the next 6–12 months unusually busy.

    Aug 06, 2026Positive0.65